PharmAla Biotech: Pioneering MDMA Therapy

In this episode of the CanadianSME Small Business Podcast, host Maheen Bari sits down with Nick Kadysh, founder and CEO of PharmAla Biotech, to uncover how this pioneering Toronto-based life sciences company is leading the way in MDMA-assisted therapies for mental health.With a career spanning regulatory leadership roles at JUUL Labs and General Electric Canada, Nick’s journey into biotechnology brings a unique blend of public affairs expertise and innovation to the healthcare space. Through PharmAla’s groundbreaking work, MDMA and MDXX-class molecules are now being manufactured and researched to treat PTSD and support mental health globally.Key Highlights:Regulatory Innovation – Overcoming challenges in MDMA manufacturing and approval.Prescriber’s Portal – A digital solution expanding access to MDMA treatments in Canada.Veteran Mental Health – How MDMA therapy is improving outcomes for PTSD patients.Global Research – PharmAla’s partnerships with leading institutions driving mental health innovation.Special Thanks to Our Partners:RBC: https://www.rbcroyalbank.com/dms/business/accounts/beyond-banking/index.htmlUPS: https://solutions.ups.com/ca-beunstoppable.html?WT.mc_id=BUSMEWAConstant Contact: https://www.constantcontact.com/landing1/new-marketer?utm_campaign=canadiansme&utm_medium=sponsorlogo&utm_source=brandIHG Hotels and Resorts: https://businessedge.ihg.com/s/registration?language=en_US&CanSMEGoogle: https://www.google.ca/For more expert insights, visit www.canadiansme.ca and subscribe to the CanadianSME Small Business Magazine. Stay innovative, stay informed, and thrive in the digital age!Disclaimer: The information shared in this podcast is for general informational purposes only and should not be considered as direct financial or business advice. Always consult with a qualified professional for advice specific to your situation.